MS

Martin Lee Stockley

ML Mission Therapeutics Limited: 8 patents #1 of 7Top 15%
CL Cancer Research Technology Limited: 1 patents #4 of 68Top 6%
Overall (2022): #9,862 of 548,613Top 2%
9
Patents 2022

Issued Patents 2022

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11472798 Compounds Alison Jones, Mark Ian Kemp, Karl Richard Gibson, Gavin Alistair Whitlock, Andrew Madin 2022-10-18
11453666 Autotaxin inhibitory compounds Ellen Catherine Macdonald, Pritom Shah, Allan Jordan, James HITCHIN, Niall Hamilton 2022-09-27
11414402 Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitors Mark Ian Kemp, Andrew Madin, Michael David Woodrow 2022-08-16
11390584 1-cyano-pyrrolidine compounds as USP30 inhibitors Alison Jones, Mark Ian Kemp, Karl Richard Gibson, Gavin Alistair Whitlock 2022-07-19
11370784 Cyano-substituted heterocycles with activity as inhibitors of USP30 Mark Ian Kemp, Andrew Madin 2022-06-28
11352339 1-cyano-pyrrolidine derivatives as DUB inhibitors Alison Jones, Mark Ian Kemp, Michael David Woodrow 2022-06-07
11319287 Cyanopyrrolidines as dub inhibitors for the treatment of cancer Mark Ian Kemp, Alison Jones 2022-05-03
11306096 4,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates for treating cancer Alison Jones, Mark Ian Kemp, Michael David Woodrow 2022-04-19
11236092 Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors Mark Ian Kemp, Michael David Woodrow, Alison Jones 2022-02-01